Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study

AIMS/INTRODUCTION: We recently reported the beneficial effect of the combination of sodium–glucose cotransporter 2 inhibitor and dipeptidyl peptidase‐4 inhibitor on daily glycemic variability in patients with type 2 diabetes mellitus. Additional favorable effects of combination therapy were explored...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Kyu Yong, Nomoto, Hiroshi, Nakamura, Akinobu, Kawata, Shinichiro, Sugawara, Hajime, Takeuchi, Jun, Nagai, So, Omori, Kazuno, Tsuchida, Kazuhisa, Miya, Aika, Shigesawa, Ikumi, Tsuchida, Kenichi, Yanagiya, Shingo, Kameda, Hiraku, Yokoyama, Hiroki, Taneda, Shinji, Kurihara, Yoshio, Aoki, Shin, Nishimoto, Naoki, Atsumi, Tatsuya, Miyoshi, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354497/
https://www.ncbi.nlm.nih.gov/pubmed/33421309
http://dx.doi.org/10.1111/jdi.13498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354497/
https://www.ncbi.nlm.nih.gov/pubmed/33421309
http://dx.doi.org/10.1111/jdi.13498

Ejemplares similares